Insider Transactions in Q3 2024 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Payment of exercise price or tax liability
|
Direct |
2,045
-4.82%
|
$173,825
$85.38 P/Share
|
|
Aug 15
2024
|
Gary Louis Corona Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,966
+21.35%
|
-
|
|
Aug 02
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
2,887
-2.25%
|
$233,847
$81.51 P/Share
|
|
Aug 02
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct |
3,490
+5.11%
|
-
|
|
Aug 02
2024
|
Matthew R. Walter SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
441
-0.86%
|
$35,721
$81.51 P/Share
|
|
Aug 02
2024
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
684
+2.57%
|
-
|
|
Aug 02
2024
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
5,063
-5.29%
|
$410,103
$81.51 P/Share
|
|
Aug 02
2024
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
5,311
+9.75%
|
-
|
|
Aug 02
2024
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
SELL
Payment of exercise price or tax liability
|
Direct |
9,210
-4.97%
|
$746,010
$81.51 P/Share
|
|
Aug 02
2024
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Exercise of conversion of derivative security
|
Direct |
14,514
+10.43%
|
-
|
|
Aug 02
2024
|
Jennifer M Kirk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
476
-0.82%
|
$38,556
$81.51 P/Share
|
|
Aug 02
2024
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,138
+3.78%
|
-
|
|
Aug 02
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Payment of exercise price or tax liability
|
Direct |
1,410
-1.62%
|
$114,210
$81.51 P/Share
|
|
Aug 02
2024
|
Michael Marinaro EVP & President, Surgical OU |
BUY
Exercise of conversion of derivative security
|
Direct |
1,670
+3.67%
|
-
|
|
Aug 02
2024
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,172
-4.58%
|
$1,471,932
$81.51 P/Share
|
|
Aug 02
2024
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,966
+8.54%
|
-
|
|
Aug 02
2024
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,729
-6.5%
|
$545,049
$81.51 P/Share
|
|
Aug 02
2024
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,132
+11.77%
|
-
|
|
Aug 02
2024
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
3,436
-2.53%
|
$278,316
$81.51 P/Share
|
|
Aug 02
2024
|
Sean Salmon EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
5,462
+7.38%
|
-
|
|
Jul 31
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,406
-2.24%
|
$112,480
$80.32 P/Share
|
|
Jul 29
2024
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,625
+23.23%
|
-
|
|
Jul 29
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
14,375
+18.66%
|
-
|
|
Jul 29
2024
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
14,375
+24.69%
|
-
|
|
Jul 29
2024
|
Michael Marinaro EVP & President, Surgical OU |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+24.61%
|
-
|
|
Jul 29
2024
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+17.85%
|
-
|
|
Jul 29
2024
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
14,375
+18.56%
|
-
|
|
Jul 29
2024
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,139
+22.58%
|
-
|
|
Jul 29
2024
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Grant, award, or other acquisition
|
Direct |
12,750
+19.49%
|
-
|
|
Jul 18
2024
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
492
+2.72%
|
$30,504
$62.76 P/Share
|